Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Vascular endothelial growth factor receptor tyrosine kinase inhibitors vandetanib (ZD6474) and AZD2171 in lung cancerEmer O Hanrahan, John V HeymachExpert Opinion on Pharmacotherapy|August 10, 2005
Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trialsEmer O Hanrahan, Bryan T Hennessy, Vicente ValeroThe Lancet. Oncology|June 3, 2004
Non-Hodgkin lymphoma: an updateBryan T Hennessy, Emer O Hanrahan, Peter A DalyJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literatureEmer O Hanrahan, Vicente Valero, Ana M Gonzalez-Angulo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinomaEmer O Hanrahan, Ana M Gonzalez-Angulo, Sharon H Giordano, et al.The Breast Journal|July 6, 2011
Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancerMerih Guray Durak, Ana M Gonzalez-Angulo, Emer O Hanrahan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancerEmer O Hanrahan, Anderson J Ryan, Helen Mann, et al.Cancer|July 28, 2005
Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factorsEmer O Hanrahan, Kristine R Broglio, Aman U Buzdar, et al.Irish Journal of Medical Science|July 14, 2023
Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in IrelandMaha AlSendi, Calvin R Flynn, Muhammad R Khan, et al.American Journal of Clinical Oncology|May 13, 2009
A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neckEmer O Hanrahan, Merrill S Kies, Bonnie S Glisson, et al.Pageof 2